In this review, we discuss the discovery and development of the first rationally designed approach to unimolecular co-agonism, which recruits the well-established pharmacology of glucagon-like peptide 1 (GLP-1) and, counterintuitively, glucagon
The standard prescribing dosing guidelines for Zepbound could look like: Disclaimer: This chart is for informational purposes only
If that's worth it to you, Ritual makes a compelling case
Recommended articles The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X Diabetes, Metabolic Syndrome and Obesity 2023, 16:1541-1554 Published Date: 30 May 2023 Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke Lee SH, Choi H, Kim KY, Lee HS, Jung JM Clinical Interventions in Aging 2023, 18:1009-1020 Published Date: 4 July 2023 Physical Activity Mediates the Relationship Between Sarcopenia and Cognitive Function Among Older Adults in Nursing Homes Yao X, Liu B, Hua N, Huang J, Zhao X Clinical Interventions in Aging 2023, 18:1863-1871 Published Date: 13 November 2023 Four-Step Co-Designing of the Reablement Strategies Targeting Sarcopenia (ReStart-S): An Exercise-Based Multicomponent Program for Older Adults Residing in Long-Term Care Settings Kumar P, Umakanth S, Marzetti E, Kalra S, N G Journal of Multidisciplinary Healthcare 2024, 17:1415-1433 Published Date: 28 March 2024 Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study Ren Q, Zhi L, Liu H Drug Design, Development and Therapy 2025, 19:5645-5652 Published Date: 3 July 2025
doi: 10.4103/0253-7176.106022, 84
